Press-release for stocks

Prices are updated after-hours

meeting crawled time : 12:00

save search

TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
TGTX | News | $13.79 -1.43% -1.45% 3.7M

Health Technology

| -0.43% | O: -0.43% H: 4.57% C: 0.0%
briumvi neurology sclerosis for meeting therapeutics

Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
MNPR | News | $0.636 -6.19% -6.6% 33K

Health Technology

| 3.55% | O: 3.55% H: 0.0% C: 0.0%
nuclear presentation for meeting imaging molecular

Legion Capital Corporation Announces 2024 Annual Meeting Of Shareholders
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
LGCP | $0.198 526.26% 500

| Email alert Add to watchlist
corporation meeting

Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
ABOS | $3.14 -0.63% -0.64% 310K

Professional, Scientific, and T...

| -5.19% | O: -4.64% H: 3.15% C: 0.29%
acu193 first neurology biomarker pharmaceuticals for meeting

Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
Published: 2024-04-16 (Crawled : 12:00) - phiopharma.com
PHIO | $0.631 -1.07% -1.08% 29K

Health Technology

| 0.0% | O: -0.15% H: 1.69% C: 0.8%
pharmaceuticals for meeting

Blue World Acquisition Corporation Postponed the Extraordinary General Meeting to Approve the Business Combination with TOYO Solar Pending A Post-Effective Amendment to The Registration Statement
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
BWAQ | $11.27 -0.08% 110

n/a

| -0.08% | O: -0.08% H: 0.0% C: 0.0%
business world corporation solar acquisition meeting blue

TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
TGTX | News | $13.79 -1.43% -1.45% 3.7M

Health Technology

| -5.02% | O: -3.94% H: 3.0% C: -0.57%
briumvi neurology presentation sclerosis for meeting therapeutics

Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-12 (Crawled : 12:00) - globenewswire.com
PRAX | $46.88 0.62% 0.62% 350K

Health Technology

| -1.91% | O: 3.52% H: 5.58% C: 2.93%
precision meeting

EISAI TO PRESENT DATA ON ROBUST NEUROLOGY PORTFOLIO AT THE 76th AMERICAN ACADEMY OF NEUROLOGY® (AAN) ANNUAL MEETING
Published: 2024-04-12 (Crawled : 12:00) - prnewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M

Health Technology

| -3.46% | O: 1.03% H: 0.49% C: -2.96%
neurology meeting

Ultragenyx Announces Upcoming Data Presentations at American Academy of Neurology (AAN) 2024 Annual Meeting
Published: 2024-04-12 (Crawled : 12:00) - globenewswire.com
RARE F | $42.37 -2.33% -2.38% 680K

Health Technology

| -15.42% | O: -4.27% H: 0.0% C: 0.0%
meeting

AppTech Payments Corp. Announces 2024 Annual Shareholder Meeting
Published: 2024-04-12 (Crawled : 12:00) - globenewswire.com
APCX | $0.9155 -5.62% -5.95% 89K

Information

| -5.05% | O: 1.01% H: 0.0% C: -1.26%
meeting

Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial
Published: 2024-04-11 (Crawled : 12:00) - globenewswire.com
PCSA M | $1.58 1.28% 1.27% 19K

Producer Manufacturing

| -38.75% | O: -32.47% H: 3.28% C: -3.83%
pharmaceuticals meeting trial

Provectus Biopharmaceuticals Announces Presentation of Cancer Immunotherapy PV-10 Poster for HNSCC at AACR 2024 Annual Meeting
Published: 2024-04-11 (Crawled : 12:00) - globenewswire.com
PVCT | News 4 | $0.195 -15.0% 56K

Manufacturing

| 11.96% | O: 0.0% H: 17.21% C: 7.19%
pv-10 presentation cancer immunotherapy for meeting

Notice of the Annual General Meeting of Orrön Energy AB
Published: 2024-04-11 (Crawled : 12:00) - globenewswire.com
CM | $47.57 0.74% 0.0% 3.5M

Finance

| -5.07% | O: -0.89% H: 0.0% C: -0.84%
energy meeting

Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K

Health Technology

| 1.85% | O: 1.85% H: 0.0% C: 0.0%
biotech fda breast cancer for meeting trial submission

Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
Published: 2024-04-11 (Crawled : 12:00) - phiopharma.com
PHIO | $0.631 -1.07% -1.08% 29K

Health Technology

| -4.69% | O: 3.8% H: 1.15% C: -1.19%
presentation cell pharmaceuticals meeting therapy

Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
QLGN | $0.301 -3.43% -3.55% 30K

Health Technology

| -24.79% | O: -2.03% H: 2.35% C: -2.76%
association direct cancer research meeting

Acrivon Therapeutics Presents Data at AACR Annual Meeting Highlighting the Capabilities of Acrivon Predictive Precision Proteomics (AP3) for the Discovery of ACR-2316, a Novel, Selective WEE1/PKMYT1 Inhibitor, and the Identification of Actionable Resistance Mechanisms to ACR-368
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
ACRV P | $9.405 -10.77% -12.07% 630K

| 7.48% | O: -2.7% H: 11.97% C: 11.0%
acr-2316 precision acr-368 for meeting therapeutics

Stellantis Annual General Meeting Live Webcast Available
Published: 2024-04-09 (Crawled : 12:00) - globenewswire.com
STLA | News | $25.77 0.08% -0.66% 6M

Manufacturing

| -4.66% | O: 1.74% H: 0.0% C: 0.0%
meeting